Novel topoisomerase I/II dual inhibitors: Design, synthesis, and molecular docking studies of 1,3-thiazoline and 1,3,4-oxadiazole derivatives with anticancer activity against lung cancer.
- DOI
- 10.1016/j.ejmech.2026.119247
- Published
- 2026 Aug 22
- Container
- European journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2026.119247,
title = {Novel topoisomerase I/II dual inhibitors: Design, synthesis, and molecular docking studies of 1,3-thiazoline and 1,3,4-oxadiazole derivatives with anticancer activity against lung cancer.},
author = {Şenoğlu S and Cantürk P and Başoğlu F and Çevik Ö and Ece A and Karakuş S},
year = {2026},
journal = {European journal of medicinal chemistry},
doi = {10.1016/j.ejmech.2026.119247},
url = {https://doi.org/10.1016/j.ejmech.2026.119247}
}RIS
TY - JOUR TI - Novel topoisomerase I/II dual inhibitors: Design, synthesis, and molecular docking studies of 1,3-thiazoline and 1,3,4-oxadiazole derivatives with anticancer activity against lung cancer. AU - Şenoğlu S AU - Cantürk P AU - Başoğlu F AU - Çevik Ö AU - Ece A AU - Karakuş S PY - 2026 JO - European journal of medicinal chemistry DO - 10.1016/j.ejmech.2026.119247 UR - https://doi.org/10.1016/j.ejmech.2026.119247 ER -
APA
S, Ş., P, C., F, B., Ö, Ç., A, E., & S, K. (2026). Novel topoisomerase I/II dual inhibitors: Design, synthesis, and molecular docking studies of 1,3-thiazoline and 1,3,4-oxadiazole derivatives with anticancer activity against lung cancer.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2026.119247
Source records
- pubmed · retrieved 2026-09-26T12:05:14.726Z